Bobba, S and Di Girolamo, N and Munsie, M and Chen, F and Pebay, A and Harkin, D and Hewitt, A and O'Connor, M and McLenachan, S and Shadforth, AMA and Watson, SL, The current state of stem cell therapy for ocular disease, Experimental Eye Research, 177 pp. 65-75. ISSN 0014-4835 (2018) [Refereed Article]
© 2018 Published by Elsevier Ltd.
Herein, we review the safety, efficacy, regulatory standards and ethical implications of the use of stem cells in ocular disease. A literature review was conducted, registered clinical trials reviewed, and expert opinions sought. Guidelines and codes of conduct from international societies and professional bodies were also reviewed. Collated data is presented on current progress in the field of ocular regenerative medicine, future challenges, the clinical trial process and ethical considerations in stem cell therapy.
A greater understanding of the function and location of ocular stem cells has led to rapid advances in possible therapeutic applications. However, in the context of significant technical challenges and potential long-term complications, it is imperative that stem cell practices operate within formal clinical trial frameworks. While there remains broad scope for innovation, ongoing evidence-based review of potential interventions and the development of standardized protocols are necessary to ensure patient safety and best practice in ophthalmic care.
|Item Type:||Refereed Article|
|Keywords:||stem cell therapy, ocular disease|
|Research Division:||Biomedical and Clinical Sciences|
|Research Group:||Ophthalmology and optometry|
|Objective Group:||Clinical health|
|Objective Field:||Clinical health not elsewhere classified|
|UTAS Author:||Hewitt, A (Professor Alex Hewitt)|
|Web of Science® Times Cited:||7|
Repository Staff Only: item control page